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Natural history of spontaneous isolated superior
mesenteric artery dissection derived from
follow-up after conservative treatment
Yang Jin Park, MD,a Kwang Bo Park, MD,b Dong-Ik Kim, MD,a Young Soo Do, MD,b
Duk-Kyung Kim, MD,c and Young-Wook Kim, MD,a Seoul, Korea
Objectives: Optimal treatment of spontaneous isolated superior mesenteric artery dissection (SISMAD) has not been
established in part because the natural history of this rare vascular disease is not well established. We attempted to
determine the natural history of SISMAD by observing patients who underwent conservative treatment.
Methods: Among 58 consecutive patients with SISMAD, 46 who underwent conservative treatment and periodic
follow-up of computed tomography (CT) angiography (CTA) were included for this study. Our first-line treatment for
SISMAD patients was conservative (n  53), reserving interventional treatment, either endovascular (n  1) or surgical
(n  4), for patients with persistent abdominal pain despite conservative treatment or signs of bowel ischemia. We
retrospectively investigated changes of the length, type, or remodeling of the dissection and superior mesenteric artery
patency on multidetector CT scan. To evaluate clinical course, presence of persistent or recurrent abdominal symptoms
was queried on an outpatient base.
Results: After 23.0 (median, range 6.5-74.2) months, follow-up CT angiograms showed diminished extent of the false
lumen size in 19 (41.3%), no change in 20 (43.5%), diminished length of dissection in 11 (23.9%), and complete
remodeling of dissection in seven (15.2%) patients. No patient showed dissection progression on follow-up angiogram.
During the follow-up period, 10 (26.3%) patients reported nonspecific, mild abdominal discomfort, however, no patient
developed recurrent abdominal pain following conservative treatment. There was no mortality related with SISMAD.
Conclusions: After conservative treatment of SISMAD, we have observed that the majority of patients showed improve-
ment or no change on both angiogram and clinical examination. We believe this observation supports an approach of
conservative treatment for patients with SISMAD. (J Vasc Surg 2011;54:1727-33.)
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6Spontaneous isolated superior mesenteric artery dissec-
tion (SISMAD) is a rare vascular disease and only 168 cases
can be found in the literature to date by MEDLINE
literature search.1,2 The development of advanced imaging
technology, in particular, abdominal computed tomogra-
phy (CT) scan appears to have increased detection of
SISMAD. Treatment options for patients with SISMAD
include conservative management with or without anti-
thrombotic therapy, endovascular therapy with superior
mesenteric artery (SMA) stent or open surgery such as
bypass or direct surgical reconstruction of the lesion. How-
ever, the natural history of SISMAD has not been fully
clarified. At our institution, before selecting a treatment op-
tion in SISMADpatients, our concerns are focused on the risk
of bowel ischemia and necrosis, mesenteric hemorrhage due
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doi:10.1016/j.jvs.2011.07.052o SMA rupture, or progression of dissection lesion. We
reviously reported our observation regarding correlation be-
ween types of SISMADonCT angiogram (CTA) and clinical
eatures and relation between wall shear stress at the SMA and
natomic features of SMA.3,4 To our knowledge, this is the
argest series of clinical follow-up of SISMAD patients from a
ingle institution. In the present study, we attempted to de-
ermine the natural history of SISMAD.
ETHODS
Fifty-eight SISMAD patients were prospectively ob-
erved at a single institution over the past 9 years from
ovember 2001 through November 2010. Patients were
reated either conservatively (n  53, 91.4%), or with
ndovascular SMA stenting (n 1) or surgical intervention
mesenteric intimo-thrombectomy and vein patch, n  2;
ortomesenteric bypass, n  2). Among patients treated
onservatively, four asymptomatic patients were lost to
ollow-up and three patients were excluded from the study
ue to short duration (6 months) of follow-up (n 2) or
eath not related to mesenteric disease (n  1). Forty-six
atients who underwent conservative treatment and peri-
dic follow-up of CTA were included in this study. To
etermine the natural course of SISMAD, we reviewed
linical features of these patients and their CT angiograms
uring the follow-up period (median, 23 months; range,
.5-74.2 months). This study was approved by the Institu-
ional Review Board of Samsung Medical Center.
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December 20111728 Park et alDiagnostic criteria of SISMAD have been previously
described.4 When asymptomatic SISMAD was detected
incidentally, patients were observed on an outpatient basis
annually. Indications for intervention, either endovascular
or surgical, included persistent abdominal pain not relieved
by conservative treatment lasting 7 days or longer, or signs
and symptoms suggestive of bowel ischemia. For symptom-
atic patients who were not indicated for intervention, con-
servative management was performed consisting of bowel
rest, intravenous fluid, and nutritional support with or
without antithrombotic therapy. Twelve patients in the
early part of this study received antithrombotic therapy
(anticoagulant, n  5, antiplatelet agents n  5, both n 
2). After observing that the clinical course of patients was
not different between patients treated with antithrombotic
agents and those not treated with antithrombotic therapy,
we did not prescribe anticoagulants or antiplatelet agents
for patients being treated conservatively thereafter.
As described by Yun et al,3 SISMAD was classified into
three types based on presence of dissection re-entry and
SMA main trunk patency at initial diagnosis (Fig 1). We
retrospectively investigated the changes of CTA findings
(length of the dissected lesion, false lumen size, patency of
SMA, change of CTA type, or remodeling of dissected
lesion of SMA) and clinical course (recurrence or persistent
abdominal symptom). Complete remodeling was defined
as no residual stenosis or occlusion at the SMA trunk, no
false lumen, or intramural thrombus on CTA. Incomplete
remodeling was defined as improved SISMAD lesion, but
showing residual stenosis or intramural thrombus on CTA.
Patients were followed in an outpatient clinic and un-
derwent CTA the first month following hospital discharge,
then, every 6 months, thereafter, until 2 years after hospital
discharge, at which point the follow-up interval was ex-
tended to 1 year in patients with no abdominal pain and
Fig 1. Angiographic classification of spontaneous isolat
patent true and false lumen revealing entry and re-entry sit
IIb, patent true lumen but thrombosed false lumen; typeinterval change on CTA. aESULTS
Among 53 patients treated conservatively, periodic
ollow-up of clinical course and CTA examination was
vailable in 46 (87%) patients for the median duration of 23
onths ranging from 7 months to 74 months.
Demographic and clinical characteristics of the enrolled
atients are shown in Table I. Median age was 50 years
range, 39-80), and 91% of patients were male. As shown in
able I, atherosclerotic risk factors were found in only 30%
f the patients. In 89.5% of patients, initial abdominal
ymptoms subsided within 7 days (median, 4; range, 1-7)
fter onset. About 80% of patients presented with severe
bdominal pain (visual analogue scale [VAS]  7), but it
as not related with meal in 84% of patients.
For symptomatic patients (n  38), follow-up clinical
eatures are shown in Table II. Abdominal pain completely
ubsided in about 90% (34/38) of patients, while four
atients continued to reportmild abdominal discomfort.Dur-
ng the follow-up period, 10 (26%) patients complained of
ecurrent abdominal discomfort but not severe enough to
equire pain killer prescription or hospital admission.
Follow-up results of CTA are also shown in Table II.
e observed improvement of dissection lesions in 19
41.3%) patients (diminished extent of false lumen size,
ength of dissection) and no change in 20 (43.5%) patients.
n seven (15.2%) patients, SISMAD showed complete re-
odeling (Fig 2) within a median time of 8.2 months
range, 3-16 months). We found that most remodeling on
TA occurred within 6 months. No patients showed dis-
ection progression or dissection of other arteries on
ollow-up CTA. We observed mild dilatation of SMA in 10
21.7%) of 46 patients, but it was not aneurysmal. In
atients showing incomplete remodeling (n  19) or no
hange (n  21) on CTA, we found that it was not always
perior mesenteric artery dissection (SISMAD):3 Type I,
pe IIa, patent true and false lumenwithout re-entry; type
superior mesenteric artery (SMA) occlusion.ed su
es; tyssociated with abdominal symptoms.
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Volume 54, Number 6 Park et al 1729At initial presentation, the types of SISMAD lesions on
CTA were categorized into type I 39%, type II 57%, and
type III 4% (Table III). Complete remodeling on CTA was
more frequently found in type II lesions (19.2%, n  5)
than in type I (11.1%, n 2) or type III lesions, though this
Table I. Demographic and clinical characteristics
(n  46)
Characteristic No. (%)
Age, median year (range) 50.0 (39-80)
Male gender 42 (91.3)
Coexisting medical conditions or
atherosclerotic risk factor
Hypertension 15 (32.6)
Diabetes mellitus 2 (4.3)
Ischemic heart disease 1 (2.2)
Hypercholesterolemia 6 (13.0)
Smoking (current or ex-smoker) 15 (32.6)
Abdominal aortic aneurysm 2 (4.3)
Intra-abdominal cancer 6 (13.0)
Clinical manifestation
Asymptomatica 8 (17.4)
Pain at the initial presentation 38 (82.6)
Mode of onset
Sudden 35 (92.1)
Insidious 3 (7.9)
Location
Epigastric/peri-umbilical pain 25 (65.8)
Ill-defined location 11 (28.9)
Back pain 2 (5.3)
Associated symptoms
Nausea 5 (13.2)
Vomiting 4 (10.5)
Diarrhea 4 (10.5)
Aggravated by meal 6 (15.8)
Pain severity scoreb
1-3 3 (7.9)
4-6 5 (13.2)
7-10 30 (78.9)
aOccasionally detected on computed tomography (CT) angiography.
bVAS, Visual analogue scale 0 to 10.
Table II. Follow-up results after conservativea treatment
Result No. (%)
Clinical features (n  38)
Relief of abdominal symptoms
Complete relief 34 (89.5)
Residual discomfort 4 (10.5)
Recurrence of symptoms
No recurrence 28 (73.7)
Recurrent abdominal discomfort 10 (26.3)
Angiographic features (n  46)
No change 20 (43.5)
Complete remodeling of dissection 7 (15.2)
Improved dissection lesion 19 (41.3)
Reduced false lumen diameter 6 (13.0)
Reduced dissection length 11 (23.9)
Reduced amount of thrombus 19 (41.3)
aConservative treatment denotes bowel rest, fluid, and nutritional replace-
ment therapy with or without antithrombotic therapy.was not statistically significant (2 test; P  .17). With wegard to the site of dissection entry, an entry site near the
onvex curvature of the SMA was the most common site
61%, 28/46). The length of dissection was not signifi-
antly associated with angiographic changes on follow-up
TA examinations (Table III). Even in a patient with total
cclusion of SMA (type III), we found that incomplete
emodeling of the dissection occurred at 10 months after
ymptom onset (Fig 3). During the follow-up period, one
atient required small bowel resection due to late develop-
ent of bowel stricture; however, no mortality related to
ISMAD occurred.
ISCUSSION
SISMAD is a rare cause of acute abdominal pain, but
he natural history of this rare vascular disease has not been
ell known. Regarding the causes of SISMAD, as we
escribed in a previous article,4 we think hemodynamic
bnormalities in the SMA at the transitional point from the
xed to relatively mobile segment of SMA at the lower
argin of the pancreas is a major cause of SMA dissection,
hich is analogous to the type II aortic dissection that starts
ust distal to the left subclavian artery. Hypertension was
ssociated in 30% of SISMAD patients, while it was associated
n 66% of patients with combined aortic and SMAdissection.4
istologic examination of the SMA wall was available in one
ISMAD patient. It showed myxoid degeneration of dis-
ected wall of SMA.
We found morphologic improvement in 41.3% of pa-
ients on CTA and complete remodeling in seven (15.2%)
atients. No patients had progression of dissection demon-
trated on CTA. Although there was no statistically signif-
cant predictor of complete remodeling of SISMAD, we
ound complete remodeling was more likely to occur in
atients with type II lesions (19.2%, n 5). In other words,
atients with a patent SMA and patent entry but no re-entry
ad a higher chance of complete remodeling. Type I lesions
patent SMA with patent entry and re-entry) showed a
ropensity for no change on follow-up angiograms. Unlike
therosclerotic lesions of the SMA, we observed total oc-
lusion due to SISMAD can recanalize and become patent
n follow-up CT examination. We do not know the reason
hy type II lesions are more likely to show complete
emodeling on CTA. But we think thrombus in the cul-de-
ac of the type IIa lesion may attribute to the process of
he wall remodeling. During the follow-up period, we
ould not find pseudoaneurysm formation at the dis-
ected segment of the SMA. At the moment, we do not
orry about the late development of pseudoaneurysm in
ISMAD patients showing improvement or no change
n CTA.
Although median 20.0 months of follow-up is not
nough to determine the natural course of SISMAD, we
ound that most angiographic change (CTA) occurred within
months after onset. Thereafter, we think the lesion became
table. All complete remodeling on follow-upCTAwas found
t median 8.2 months after onset of SISMAD.
Recently, Cho et al2 reported that the SMA stenosis
as related to symptoms in SISMAD patients suggesting
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December 20111730 Park et althat abdominal pain in SISMAD is due to visceral ischemia.
In our series, most patients presented with severe abdomi-
nal pain at initial presentation, but it subsided in a few days
in most patients and the pain was not aggravated by meal.
In our previous study, we found there was no correlation
between CTA type and pain severity.3 We assume that pain
in SISMAD is not due to an ischemic cause. The presence of
an arterial dissection and mesenteric hematoma themselves
can be a cause of abdominal pain. Some authors describe an
inflammatory response around the arterial dissection stim-
ulating the visceral nerve plexus as a cause of abdominal
pain.5 In our prior study, we found a positive correlation
between pain severity and dissection length,3 and therefore,
it seems logical that longer dissections could cause more
perivascular inflammation and pain.
SISMAD treatments reported in the literature can be
classified into conservative management, endovascular
therapy, or open surgery. Gobble et al1 thoroughly re-
Fig 2. Complete remodeling of superior mesenteric ar
(CT) angiogram:A, initial CT scan showing double-lume
lesion on the anterior wall of the SMA (type IIa SISMAD
treatment shows disappearance of the double-lumen sign
a reconstructed view of the SMA (bottom).viewed the literature and accumulated 106 cases of aISMAD. Excluding 10 asymptomatic cases, 96 symptom-
tic patients with SISMADwere treated with either expect-
nt management, anticoagulation, open surgery, or endo-
ascular stent placement. Of these patients, 48% were
anaged successfully with conservative management (ex-
ectant and anticoagulation). In those patients, in whom
onservative management was not successful in relieving
ymptoms, and were treated with open surgery or SMA
tenting, a mortality rate of 17.7% was observed. Because
ISMAD is rarely seen, recommendations for an optimal
reatment vary widely based on experience with small num-
er of cases. In our experience, among 58 patients with
ISMAD, 49 (84.5%) patients were symptomatic. Exclud-
ng five patients who underwent open or endovascular
herapy due to prolonged unrelieved pain, 91.4% (53/58)
f all SISMAD and 89.8% (44/49) of symptomatic patients
ave been successfully treated with conservative manage-
ent. Among them, 75.5% (40/53) were not prescribed
SMA) dissection on follow-up computed tomography
on an axial view (top) and a windsock-shaped dissection
follow-up CT angiogram at 7 months after conservative
xial view (top) and complete remodeling of the SMA ontery (
n sign
); B,
on anticoagulants or antiplatelet agents. In our previous re-
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Volume 54, Number 6 Park et al 1731port, we noted that there was no difference in clinical
courses of patients treated with antithrombotic agents or
not.3 Regarding the indications for intervention, we sug-
gested persistent abdominal pain for 7 days or longer
despite conservative treatment or signs of acute bowel
ischemia. Symptomatic patients were treated by conserva-
tivemanagement as first-line treatment, consisting of bowel
rest, intravenous fluids, and nutritional support with or
without antithrombotic therapy. With conservative treat-
ment, abdominal pain subsided in 7 days at the longest
(median, 4 days; range, 1-7). Based on this observation, we
recommend interventional treatment, either endovascular
or surgical, for patients with persistent abdominal pain not
relieved by conservative treatment lasting 7 days or longer,
or signs and symptoms suggestive of acute bowel ischemia.
We found that about 30% of SISMAD patients were hyper-
tensive. That was a remarkable difference from the patients
with aortic dissection. If SISMAD patients were hyperten-
sive, strict control of blood pressure was attempted, but
antihypertensive medication was not prescribed in order to
deter progression of SMA dissection.
Surgical treatments such as thrombectomy, intimec-
tomy and patch angioplasty, and aortomesenteric bypass
have been reported in small number series.6-11 Morris et
al12 have recently proposed that patients with SISMAD
should undergo surgery when arterial rupture occurs or
bowel necrosis is apparent on a CT scan. In our series, four
patients required surgical treatment (aortomesenteric by-
pass [two] and thrombo-intimectomy and vein patch
[two]). Open surgery was performed in the earlier part of
our study for patients with unrelieved abdominal pain. Of
the patients undergoing open surgery for SISMAD, only
Table III. Results of follow-up CT angiograms according
dissection lesions
Characteristics No. (%)
Complete
(n
Types of SISMADb
I 18 (39.1) 2 (
II 26 (56.5) 5 (
IIa 10 (21.7) 3 (
IIb 16 (34.8) 2 (
III 2 (4.3) 0
Location of entry sitec
Zone 1 5 (10.9) 1 (
Zone 2 28 (60.9) 4 (
Zone 3 13 (28.2) 2 (
Length of dissection
40 mm 14 (30.4) 2 (
40-80 mm 18 (39.1) 1 (
80 mm 14 (30.4) 4 (
CT, Computed tomography; SISMAD, superior mesenteric artery dissectio
aComplete remodeling is defined as no residual stenosis or occlusion in SM
Incomplete remodeling is defined as improved SMA dissection lesion show
angiogram.
bType I, patent true and false lumen revealing entry and re-entry sites; type I
thrombosed false lumen; type III, SMA occlusion.
cZone 2, around SMA convex curvature; zone 1, SMA proximal to zone 2;one (1/46, 2.2%) patient was found to have bowel gan- wrene. One patient developed late small bowel stricture
equiring segmental bowel resection 6 months after symp-
om onset. This was assumed to be a late complication of
ery short segment bowel ischemia.
Recently, some authors have reported the clinical effi-
iency of endovascular stent insertion for the treatment of
ISMAD.1,13-15 Endovascular therapy for SISMAD is a less
nvasive treatment alternative compared with open repair
or patients requiring interventional treatment. Endovascu-
ar therapy has limitations in that direct visualization of the
owel is not possible, and there is risk of arterial rupture. In
ur series, we performed SMA stenting for a patient with
ersistent abdominal pain and concomitant right colon
ancer. During follow-up examination, the SMA stent was
ound to be occluded at 18 months, but the patient re-
ained without abdominal symptoms. Some authors sug-
est a SMA stent if an intimal flap or a short SMA stenosis
s present,16 but SMA stent is known to have a higher risk of
tent thrombosis than other site arteries in the long term.
o prevent acute or subacute thrombosis after SMA stenting,
stent used for SMA needs to have minimal shortening and
ood flexibility, and it must not change location as a result of
he continuous movement of the mesentery.17 Before choos-
ng SMA stenting for the treatment of SISMAD, we consid-
red younger patients compared with patients with athero-
clerotic SMA occlusion. We think it is a different situation
rom SMA stenting in old patients with atherosclerotic
MA disease.
In conclusion, we found the majority of SISMAD lesions
howed improvement or no change on follow-up CTA and
emained symptom free on clinical evaluation after conserva-
ive treatment. To understand the natural course of SISMAD,
e type, location of the entry site, and length of the
elinga Incomplete remodelinga
(n  19)
No change
(n  20)
5 (27.8) 11 (61.1)
12 (46.2) 9 (34.6)
4 (40.0) 3 (30.0)
8 (50.0) 6 (27.5)
2 (100) 0
2 (40.0) 2 (40.0)
12 (42.9) 12 (42.9)
5 (38.5) 6 (46.2)
5 (35.7) 7 (50.0)
8 (44.4) 9 (50.0)
6 (42.9) 4 (28.6)
, superior mesenteric artery.
k, no false lumen, or intramural thrombus on a follow-up CT angiogram.
sidual stenosis of SMA trunk or intramural thrombus on a follow-up CT
tent true and false lumen without re-entry; type IIb, patent true lumen but
3, SMA distal to zone 2.to th
remod
 7)
11.1)
19.2)
30.0)
12.5)
20.0)
14.2)
15.4)
14.3)
5.6)
28.5)
n; SMA
A trun
ing re
Ia, pae can make an inference from our observations, and these
A on
JOURNAL OF VASCULAR SURGERY
December 20111732 Park et alobservations support conservative treatment as the first-line
treatment for most patients with SISMAD.
Parts of the results of our previous study have been
reused (eg, Fig 1, angiographic classification of SISMAD)
with full acknowledgment from the European Journal of
Vascular and Endovascular Surgery.3
AUTHOR CONTRIBUTIONS
Conception and design: YJ, YW
Analysis and interpretation: YJ, KB, YW
Data collection: YJ, KB, DI, YS, YW
Writing the article: YJ, YW
Critical revision of the article: YJ, KB, DI, YS, DK, YW
Final approval of the article: YJ, KB, DI, YS, DK, YW
Statistical analysis: YJ
Obtained funding: Not applicable
Overall responsibility: YW
REFERENCES
Fig 3. Incomplete remodeling of superior mesenteric a
(CT) angiography: A, initial CT scan showing total occ
4.5-cm-long nonvisualization of the proximal SMA (type
CT angiogram at 10 months after conservative treatm
short-segment stenotic lesion (arrowhead) at the mid-SM1. Gobble RM, Brill ER, Rockman CB, Hecht EM, Lamparello PJ,
Jacobowitz GR, et al. Endovascular treatment of spontaneous dis-sections of the superior mesenteric artery. J Vasc Surg 2009;
50:1326-32.
2. Cho BS, Lee MS, Lee MK, Choi YJ, Kim CN, Kang YJ, et al.
Treatment guidelines for isolated dissection of the superior mesen-
teric artery based on follow-up CT findings. Eur J Vasc Endovasc
Surg 2011;41:780-5.
3. Yun WS, Kim YW, Park KB, Cho SK, Do YS, Lee KB, et al. Clinical and
angiographic follow-up of spontaneous isolated superior mesenteric
artery dissection. Eur J Vasc Endovasc Surg 2009;37:572-7.
4. Park YJ, Park CW, Park KB, Roh YN, Kim DI, Kim YW. Inference from
clinical and fluid dynamic studies about underlying cause of spontaneous
isolated superior mesenteric artery dissection. J Vasc Surg 2011;53:80-6.
5. Furukawa H, Moriyama N. Spontaneous dissection of the superior
mesenteric artery diagnosed on multidetector helical CT. J Comput
Assist Tomogr 2002;26:143-4.
6. Krupski WC, Effeney DJ, Ehrenfeld WK. Spontaneous dissection of the
superior mesenteric artery. J Vasc Surg 1985;2:731-4.
7. Vignati PV, Welch JP, Ellison L, Cohen JL. Acute mesenteric ischemia
caused by isolated superior mesenteric artery dissection. J Vasc Surg
1992;16:109-12.
8. Solis MM, Ranval TJ, McFarland DR, Eidt JF. Surgical treatment of
superior mesenteric artery dissecting aneurysm and simultaneous celiac
artery compression. Ann Vasc Surg 1993;7:457-62.
9. Sparks SR, Vasquez JC, Bergan JJ, Owens EL. Failure of nonoperative
(SMA) dissection on follow-up computed tomography
n (arrow) of proximal SMA on an axial view (top) and
ISMAD, bottom) on reconstructed image; B, follow-up
hows patent SMA on an axial view (top) and residual
a reconstructed view (bottom).rtery
lusio
III S
ent smanagement of isolated superior mesenteric artery dissection. Ann Vasc
Surg 2000;14:105-9.
11
1
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 6 Park et al 173310. Gouëffic Y, Costargent A, Dupas B, Heymann MF, Chaillou P, Patra P.
Superior mesenteric artery dissection: case report. J Vasc Surg 2002;35:
1003-5.
11. Picquet J, Abilez O, Pénard J, Jousset Y, Rousselet MC, Enon B.
Superficial femoral artery transposition repair for isolated superior mes-
enteric artery dissection. J Vasc Surg 2005;42:788-91.
12. Morris JT, Guerriero J, Sage JG, Mansour MA. Three isolated superior
mesenteric artery dissections: update of previous case reports, diagnos-
tics, and treatment options. J Vasc Surg 2008;47:649-53.
13. Leung DA, Schneider E, Kubik-Huch R, Marincek B, Pfammatter T.
Acute mesenteric ischemia caused by spontaneous isolated dissection of
the superior mesenteric artery: treatment by percutaneous stent place-
ment. Eur Radiol 2000;10:1916-9.14. Miyamoto N, Sakurai Y, Hirokami M, Takahashi K, Nishimori H, Tsuji
K, et al. Endovascular stent placement for isolated spontaneous dissec- Stion of the superior mesenteric artery: report of a case. Radiat Med
2005;23:520-4.
5. Casella IB, BoschMA, SousaWO Jr. Isolated spontaneous dissection of
the superior mesenteric artery treated by percutaneous stent placement:
case report. J Vasc Surg 2008;47:197-200.
6. Cho YP, Ko GY, Kim HK, Moon KM, Kwon TW. Conservative
management of symptomatic spontaneous isolated dissection of the
superior mesenteric artery. Br J Surg 2009;96:720-3.
7. Kim JH, Roh BS, Lee YH, Choi SS, So BJ. Isolated spontaneous
dissection of the superior mesenteric artery: percutaneous stent place-
ment in two patients. Korean J Radiol 2004;5:134-8.ubmitted May 19, 2011; accepted Jul 11, 2011.
